Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.
about
Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based ProteomicsA Plasmodium α/β-hydrolase modulates the development of invasive stagesEnlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied researchSusceptibility to Plasmodium yoelii Preerythrocytic Infection in BALB/c Substrains Is Determined at the Point of Hepatocyte InvasionOf men in mice: the success and promise of humanized mouse models for human malaria parasite infections.Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malariaMalaria Parasite Liver Infection and Exoerythrocytic Biology.CD40 is required for protective immunity against liver stage Plasmodium infectionThe innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin.Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionAn ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycleModeling malaria in humanized mice: opportunities and challenges.An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection.The use of transgenic parasites in malaria vaccine research.Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites.Humanized mouse models infected with human Plasmodium species for antimalarial drug discovery.Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal.An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.Humanized Mouse Models for the Study of Human Malaria Parasite Biology, Pathogenesis, and Immunity.PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitroOX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites
P2860
Q27973871-B6CF00F8-CE9A-47CA-BE31-D953CBDB77B1Q27973903-8C971826-6E96-4338-AED1-1A18D7FF3CA3Q28085135-E23387FF-8E38-4209-AC70-FD1577BE98F4Q29031063-647A5816-542C-4B5B-B462-3C21F922DA03Q33559521-CF7EA028-5D01-4E5A-9DF2-889642663BD3Q33855899-7E6FE7DD-1DAA-4243-BA02-BED335ED27E1Q33927133-704AB0D9-1E39-4F2C-96D2-D31CA6409C89Q33960093-459CB024-AD87-436D-97B4-9281D6D4247BQ34298647-5EC4186B-DA6B-4F54-95CF-59129DA81916Q34440997-3A091C14-50A2-4DB5-9CA0-8138A66466A0Q34552223-33D00304-28EB-4ABF-94DA-5EC08E6C71EFQ35122368-C08F7AFF-DBCA-4C15-A3B2-8EF5B183541EQ35513962-F354ABA6-23D3-45CA-A97A-DA14D3CE7D1FQ35606514-7B5618CE-8E55-4E0B-B90A-1301300213EAQ35822725-6F4A2393-9085-4564-A2CD-22C920100061Q36238031-E125EC03-E8B3-4649-8ED3-30F2558263FFQ36825361-45A95CDD-129D-4F59-8020-5F105CE4B96DQ38354353-98D68342-C497-4AFC-AE07-C59A68A643F8Q38794455-D4EFC0CE-8FB5-4DDD-8F4A-DBB45DCE8276Q39170404-9F5540BC-24FE-41ED-9AD6-97CF7297164BQ39318510-82DDE1BD-7261-4A6D-A569-780C090E2F52Q40385272-88DF1CEA-75F2-4581-9D9D-73AF210386D8Q40438040-47B5B936-CC4E-4B3F-9AEC-605735A085E4Q46252657-7B039A12-32DD-40EF-989C-98DF3A489C03Q47099112-BA4D97D9-9456-418E-A19F-1E72BCB9567BQ47281170-60C997B4-E94E-4881-99E1-A6E4E1A27471Q48018507-8ABA3372-8677-4466-AECA-EAB31A9C4849Q52350559-D611A595-8141-4C14-BA42-6E095D6DA1ADQ52715900-CD4676A8-6D25-4784-8D3B-43DAA0B46FF3Q53688052-99433E0B-247D-48DC-8CAB-C16D5F67930CQ54049693-37F0577B-21DC-4A7D-A274-CDD6E0E07121Q56360727-59249F0F-BB22-4139-A2C4-47439D94EE0D
P2860
Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Model for in vivo assessment o ...... l antibodies and immune serum.
@en
Model for in vivo assessment o ...... l antibodies and immune serum.
@nl
type
label
Model for in vivo assessment o ...... l antibodies and immune serum.
@en
Model for in vivo assessment o ...... l antibodies and immune serum.
@nl
prefLabel
Model for in vivo assessment o ...... l antibodies and immune serum.
@en
Model for in vivo assessment o ...... l antibodies and immune serum.
@nl
P2093
P2860
P50
P356
P1476
Model for in vivo assessment o ...... l antibodies and immune serum.
@en
P2093
Alexis Kaushansky
Alida Coppi
Alyse Douglass
Brandon K Sack
Fidel Zavala
Gloria Gonzalez-Aseguinolaza
Jessica L Miller
Photini Sinnis
P2860
P304
P356
10.1128/IAI.01249-13
P407
P577
2013-12-09T00:00:00Z